Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.11 USD
Change Today -0.02 / -1.77%
Volume 67.3K
ATHX On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 11:16 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Warren Sherman M.D., F.A.C.C,F.S.C.A.I

Scientific and Clinical Advisor,Athersys, Inc.
AgeTotal Calculated CompensationThis person is connected to 89 board members in 4 different organizations across 5 different industries.

See Board Relationships
64--

Background*

Dr. Warren Sherman, M.D., F.A.C.C, F.S.C.A.I has been the Chief Medical Officer of Celyad SA since November 1, 2014. Dr. Sherman is a renowned American interventional cardiologist with more than 30 years’ experience in the field of cardiology, with a focus in cell-based therapies for treating patients post myocardial infarction and with heart failure. Before joining Cardio3 BioSciences, Dr. Sherman was at the Columbia University Medical Center in New York, where he served ...

Read Full Background

Corporate Headquarters*

3201 Carnegie Avenue
Cleveland, Ohio 44115

United States

Phone: 216-431-9900
Fax: 216-361-9495

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Massachusetts Institute of Technology
Bachelor's Degree
SUNY Upstate Medical University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATHX:US $1.11 USD -0.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$599.8K
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$437.4K
David J. Mazzo B.A (Hons), B.Sc. (Hons.), M.Sc., Ph.D.Chief Executive Officer and Director
Caladrius Biosciences, Inc.
--
Zami Aberman Executive Chairman and Chief Executive Officer
Pluristem Therapeutics, Inc.
$503.7K
Silviu Itescu MBBS (Hons), FRACP, FACP, FACR, FTSEFounder, Chief Executive Officer, Managing Director, Chairman of Scientific Advisory Board, Executive Director and Member of Science and Technology Committee
Mesoblast Limited
A$1.8M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ATHERSYS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.